et al. studied 91 MDD patients and reported a decrease in IL-8 and IL-1β concentration levels during venlafaxine and paroxetine treatment after 8-weeks as well as a decrease in the number of points in the Hamilton Depression Rating Scale [28]. This evidence concerns the gene IL1B and depressive symptom measurement.